Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fouque

Showing results (521-530 of 656) with videos related to

Pageof 66
Sort By:
Diabetologia|January 24, 2007
Acute and selective regulation of glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase in adipose tissue by thiazolidinediones in type 2 diabetesT Cadoudal, J M Blouin, M Collinet, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 11, 2019
The nephrology crystal ball: the medium-term futureCarmine Zoccali, Peter J Blankestijn, Annette Bruchfeld, et al.
International Urology and Nephrology|November 20, 2017
From bench to the hemodialysis clinic: protein-bound uremic toxins modulate NF-κB/Nrf2 expressionMilena B Stockler-Pinto, Christophe O Soulage, Natália A Borges, et al.
Lancet (London, England)|May 27, 2014
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failureAlberto Ortiz, Adrian Covic, Danilo Fliser, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 28, 2017
Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKDSophie Liabeuf, Jean-Philippe Ryckelynck, Najeh El Esper, et al.
Parasites & Vectors|December 6, 2025
Multisectoral approaches to the prevention and control of vector-borne diseases: lessons learned from case studiesJoão Bueno Nunes, Rodrigo Gurgel-Gonçalves, Vanessa Resende Nogueira Cruvinel, et al.
Gut Microbes|July 12, 2025
A specifically designed multi-biotic reduces uremic toxin generation and improves kidney functionAlice Beau, Jane Natividad, Berengère Benoit, et al.
Clinical Kidney Journal|April 17, 2020
Impact of age on cardiovascular drug use in patients with chronic kidney diseaseCédric Villain, Sophie Liabeuf, Marie Metzger, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2009
The transactivating function 1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17beta-estradiolAudrey Billon-Galés, Coralie Fontaine, Cédric Filipe, et al.
Journal of Nephrology|June 12, 2021
Is a treat-to-target approach to lipid-lowering therapy appropriate in patients with chronic kidney disease? A prospective French cohort studyZiad A Massy, Epiphane Kolla, Jean Ferrières, et al.
Pageof 66

Showing results (521-530 of 656) with videos related to

Sort By:
Pageof 66
Diabetologia|January 24, 2007
Acute and selective regulation of glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase in adipose tissue by thiazolidinediones in type 2 diabetesT Cadoudal, J M Blouin, M Collinet, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 11, 2019
The nephrology crystal ball: the medium-term futureCarmine Zoccali, Peter J Blankestijn, Annette Bruchfeld, et al.
International Urology and Nephrology|November 20, 2017
From bench to the hemodialysis clinic: protein-bound uremic toxins modulate NF-κB/Nrf2 expressionMilena B Stockler-Pinto, Christophe O Soulage, Natália A Borges, et al.
Lancet (London, England)|May 27, 2014
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failureAlberto Ortiz, Adrian Covic, Danilo Fliser, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 28, 2017
Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKDSophie Liabeuf, Jean-Philippe Ryckelynck, Najeh El Esper, et al.
Parasites & Vectors|December 6, 2025
Multisectoral approaches to the prevention and control of vector-borne diseases: lessons learned from case studiesJoão Bueno Nunes, Rodrigo Gurgel-Gonçalves, Vanessa Resende Nogueira Cruvinel, et al.
Gut Microbes|July 12, 2025
A specifically designed multi-biotic reduces uremic toxin generation and improves kidney functionAlice Beau, Jane Natividad, Berengère Benoit, et al.
Clinical Kidney Journal|April 17, 2020
Impact of age on cardiovascular drug use in patients with chronic kidney diseaseCédric Villain, Sophie Liabeuf, Marie Metzger, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2009
The transactivating function 1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17beta-estradiolAudrey Billon-Galés, Coralie Fontaine, Cédric Filipe, et al.
Journal of Nephrology|June 12, 2021
Is a treat-to-target approach to lipid-lowering therapy appropriate in patients with chronic kidney disease? A prospective French cohort studyZiad A Massy, Epiphane Kolla, Jean Ferrières, et al.
Pageof 66